Target intelligence / Profile preview

Ribosomal protein L6 pseudogene 30 (RPL6P30)

Target: RPL6P30
Molecular classification: Other (Pseudogene), Ribosomal protein pseudogene

Overview

Ribosomal protein L6 pseudogene 30 (RPL6P30) is a processed pseudogene in the human genome that shares sequence similarity with the functional ribosomal protein L6 gene (RPL6)[1][4][7]. As a pseudogene, RPL6P30 does not encode a functional protein and has no known physiological, therapeutic, or pathological role[1][4][7]. It is one of several noncoding genomic copies derived from RPL6, and there is no evidence that RPL6P30 is transcribed into a functional RNA or impacts human disease or drug response[1][6][7].

Other names: RPL6_11_1767RPL6P30

Biological functions

Other (pseudogene; no known coding or regulatory protein function)

Disease associations

Other (no established disease association for this pseudogene)

Beyond the preview

Go deeper on Ribosomal protein L6 pseudogene 30 (RPL6P30).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L6 pseudogene 30 (RPL6P30).

Explore the full profile